We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Acute Kidney Injury and Chronic Kidney Disease Closely Entwined

By LabMedica International staff writers
Posted on 13 Jul 2014
Print article
Common risk factors of acute kidney injury (AKI) and chronic kidney disease (CKD) include advanced age, diabetes, and high blood pressure.

AKI is sudden loss of kidney function; CKD develops slowly over many years. A comprehensive analysis by scientists at the National Institutes of Health (NIH; Bethesda, MD, USA) and George Washington University Medical Center (Washington DC, USA) suggests that each disease is a risk factor for developing the other. They share other risk factors as well as causes for the diseases to become worse, and also outcomes. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; Bethesda, MD, USA) recommend that people with either disease should be monitored for both.

Analyzing large observational studies, the scientists saw that CKD and AKI were also risk factors for development of cardiovascular disease, progressive decreases in kidney function that can lead to kidney failure, diminished quality of life, disability, and premature death. The findings were published July 3, 2014, in the New England Journal of Medicine (NEJM).

The investigators found that new cases of AKI are increasing among hospitalized patients, possibly due to the aging population and rising rates of sepsis, a potentially life-threatening blood infection that can cause AKI. However, they found that preexisting CKD is the most important risk factor for AKI, increasing the odds by as much as 10 times. Conversely, patients with AKI had a 13-fold increased risk of CKD that progressed to kidney failure, compared to those without AKI. And the risk of kidney failure rose to 40 times if patients had both AKI and preexisting CKD.

Observational data in the 2007 US Renal Data System Annual Data Report suggest that few people with AKI see physicians and/or cardiologists after being discharged from hospital.

Paul Kimmel, MD, director of the Acute Kidney Injury program at the NIH's National Institute of Diabetes and Digestive and Kidney Diseases and lead author of the NEJM article, commented, "Physicians have been taught for decades to consider AKI and CKD as separate, but our study shows that we have to approach the two diseases as interconnected. When people have chronic kidney disease, their doctors should be on the lookout for acute kidney injury. And when people have recovered from acute kidney injury, they should promptly follow up with their doctor––and a kidney specialist to monitor their kidney function for long-term consequences related to progression of CKD."

The NIDDK, a component of the NIH, conducts and supports research on diabetes and other endocrine and metabolic diseases; digestive diseases, nutrition, and obesity; and kidney, urologic, and hematologic diseases. It covers the full range of medicine afflicting people of all ages and ethnic groups. These diseases represent some of the most common, severe, and disabling conditions affecting Americans.

Related Links:

National Institutes of Health
George Washington University Medical Center 
National Institute of Diabetes and Digestive and Kidney Diseases


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.